The Role of Vascular Flt-1 in Endothelial-Pericyte Interactions

血管 Flt-1 在内皮-周细胞相互作用中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Blood vessel formation requires a group of endothelial cells with heterogeneous responses to signaling inputs. During development, endothelial cells respond differentially to vascular endothelial growth factor (VEGF)-A signaling to adopt phenotypes required for network expansion. Abnormal vascular development associated with pathological conditions such as tumorigenesis or diabetic retinopathy likely results in part from loss of regulated endothelial heterogeneity. VEGF receptor Flt-1 (VEGFR-1) contributes to network formation via heterogeneous expression of the soluble isoform (sFlt-1) that in turn spatially regulates VEGF signaling to provide local sprout guidance to emerging vessel sprouts (Chappell et al, 2009). Phenotypic heterogeneity of endothelial cells in developing vessels is likely important for other aspects of vascular development, such as endothelial interactions with perivascular cells known as pericytes. Pericytes provide structural stability to maturing vessels, and perturbations in endothelial-pericyte interactions contribute to vascular pathologies. Thus, it is intriguing to speculate that endothelial phenotypic heterogeneity is modulated by Flt-1 regulation of VEGF signaling, and that aspects of this heterogeneity facilitate proper endothelial-pericyte interactions. One primary objective of this study therefore is to investigate how Flt-1 spatially regulates endothelial cell heterogeneity to establish proper vascular morphogenesis in vivo. Vascular morphology will be observed in developing mouse retinas with mosaic flt-1 expression via use of flt-1 conditional deletion mice. In vivo and in vito observations will then be used to generate a computational model for Flt-1 activity in regulating the phenotypic heterogeneity of endothelial cells and overall vessel morphology. In addition, the role of Flt-1 in spatially regulating endothelial-pericyte associations will be explored with in viro assays. In embryonic stem (ES) cell-derived vessels, VEGF signaling will be perturbed via genetic manipulation of flt-1 expression. Endothelial-pericyte interactions will be evaluated to characterize the spatial regulation of pericyte recruitment and investment. To assess the effect of altered spatial distribution of flt-1 expression on endothelial-pericyte interactions, mosaic vessels composed of wild-type (WT) and flt-1 mutant cells will be evaluated for pericyte investment. A computational model simulating how Flt-1 promotes vessel endothelial cell heterogeneity to regulate pericyte-endothelial cell interactions will be created as a tool to understand the biological consequences of disruptions in flt-1 expression (e.g. tumor setting). Observations from in vitro experiments will guide the construction and testing of this in silico model. Lastly, the mechanisms by which Flt-1 regulates pericyte-endothelial interactions in vivo will be characterized. Retinal vasculature from developing flt-1 conditional deletion mice will be evaluated for mosaic flt-1 expression and investment of pericytes. Simulations generated by the computer model for Flt-1 regulation of pericyte associations will provide a means for interpreting, analyzing, and advancing experimental observations and approaches.
描述(由申请人提供):血管形成需要一组对信号输入的异质反应的内皮细胞。在发育过程中,内皮细胞对血管内皮生长因子(VEGF)的反应差异,以采用网络扩展所需的表型的信号。与肿瘤发生或糖尿病性视网膜病有关的病理状况相关的异常血管发育可能部分是由于受调节的内皮异质性的丧失而导致的。 VEGF受体FLT-1(VEGFR-1)通过可溶性同工型(SFLT-1)的异质表达有助于网络形成,这反过来又在空间上调节VEGF信号以提供局部发芽指导,以提供新兴的血管芽(Chappell等,2009)。内皮细胞在发育中的血管中的表型异质性对于血管发育的其他方面可能很重要,例如与被称为周细胞周围的周围的内皮相互作用。周细胞为成熟的血管提供结构稳定性,内皮 - 周期性相互作用的扰动有助于 血管病理。因此,猜测这种内皮表型异质性很有趣 通过FLT-1调节VEGF信号传导调节,并且这种异质性的各个方面有助于适当的内皮 - 周期性相互作用。 因此,这项研究的主要目标 是为了研究FLT-1在空间上如何调节内皮细胞异质性以在体内建立适当的血管形态发生。通过使用FLT-1条件缺失小鼠,将观察到具有Mosaic FLT-1表达的小鼠视网膜的血管形态。然后,体内和Vito观察结果将用于生成用于调节内皮细胞表型异质性和整体血管形态的表型异质性的计算模型。此外,将在Viro分析中探索FLT-1在空间调节内皮 - 周围环境中的作用。在胚胎(ES)细胞来源的血管中,VEGF信号传导将通过遗传操纵FLT-1表达而受到干扰。将评估内皮 - 周期性相互作用,以表征周围招募和投资的空间调节。为了评估FLT-1表达的空间分布改变对内皮 - 周期性相互作用的影响,将评估由野生型(WT)和FLT-1突变细胞组成的镶嵌血管进行周围投资。模拟FLT-1如何促进血管内皮细胞异质性以调节周细胞内皮细胞相互作用的计算模型将被创建为了解FLT-1表达中破坏的生物学后果(例如肿瘤设置)。体外实验的观察结果将指导在计算机模型中的构建和测试。最后,将表征FLT-1调节生周内皮相互作用的机制。将评估来自发育中的FLT-1有条件缺失小鼠的视网膜脉管系统,以进行镶嵌FLT-1表达和周细胞的投资。计算机模型为FLT-1调节生成的仿真将提供一种解释,分析和推进实验观察和方法的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Christopher Chappell其他文献

John Christopher Chappell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Christopher Chappell', 18)}}的其他基金

A Tissue-Specific Soluble Platelet-Derived Growth Factor Receptor-beta Isoform Retains Functional Capacity
组织特异性可溶性血小板衍生生长因子受体-β亚型保留功能能力
  • 批准号:
    10668031
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)
KUH 弗吉尼亚综合研究培训中心 (IGNITE KUH)
  • 批准号:
    10285526
  • 财政年份:
    2021
  • 资助金额:
    $ 11.82万
  • 项目类别:
Integrated Virginia Research Training Centers in KUH (IGNITE KUH)
KUH 弗吉尼亚综合研究培训中心 (IGNITE KUH)
  • 批准号:
    10657702
  • 财政年份:
    2021
  • 资助金额:
    $ 11.82万
  • 项目类别:
Vascular Basement Membrane Composition Regulates Pericyte Investment in Developing Blood Vessels
血管基底膜成分调节周细胞在血管发育中的投资
  • 批准号:
    10449094
  • 财政年份:
    2019
  • 资助金额:
    $ 11.82万
  • 项目类别:
Vascular Basement Membrane Composition Regulates Pericyte Investment in Developing Blood Vessels
血管基底膜成分调节周细胞在血管发育中的投资
  • 批准号:
    10198032
  • 财政年份:
    2019
  • 资助金额:
    $ 11.82万
  • 项目类别:
Flt-VEGF-Cx43 Regulation of Vascular Pericyte Investment
Flt-VEGF-Cx43 对血管周细胞投资的调节
  • 批准号:
    9324428
  • 财政年份:
    2016
  • 资助金额:
    $ 11.82万
  • 项目类别:
The Role of Vascular Flt-1 in Endothelial-Pericyte Interactions
血管 Flt-1 在内皮-周细胞相互作用中的作用
  • 批准号:
    8969688
  • 财政年份:
    2014
  • 资助金额:
    $ 11.82万
  • 项目类别:
The Role of Vascular Flt-1 in Endothelial-Pericyte Interactions
血管 Flt-1 在内皮-周细胞相互作用中的作用
  • 批准号:
    8467035
  • 财政年份:
    2012
  • 资助金额:
    $ 11.82万
  • 项目类别:
Flt-1 (VEGFR-1) Regulation of Endothelial Cell Sprouting and Vessel Morphogenesis
Flt-1 (VEGFR-1) 调节内皮细胞出芽和血管形态发生
  • 批准号:
    7614747
  • 财政年份:
    2009
  • 资助金额:
    $ 11.82万
  • 项目类别:
Flt-1 (VEGFR-1) Regulation of Endothelial Cell Sprouting and Vessel Morphogenesis
Flt-1 (VEGFR-1) 调节内皮细胞出芽和血管形态发生
  • 批准号:
    7771689
  • 财政年份:
    2009
  • 资助金额:
    $ 11.82万
  • 项目类别:

相似国自然基金

DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
  • 批准号:
    42207312
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    60 万元
  • 项目类别:
    面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
  • 批准号:
    41876101
  • 批准年份:
    2018
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
  • 批准号:
    81803848
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
DRUG DISCOVERY BY DIRECTED EVOLUTION IN MAMMALIAN CELLS
通过哺乳动物细胞定向进化发现药物
  • 批准号:
    10644749
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
Pericyte reprogramming in fibrosis
纤维化中的周细胞重编程
  • 批准号:
    10578526
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 11.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了